Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Liabilities: 2020-2022

Historic Total Liabilities for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $30.0 million.

  • Candel Therapeutics' Total Liabilities fell 17.76% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 17.76%. This contributed to the annual value of $30.0 million for FY2022, which is 19.58% up from last year.
  • As of FY2022, Candel Therapeutics' Total Liabilities stood at $30.0 million, which was up 19.58% from $25.1 million recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Total Liabilities ranged from a high of $30.0 million in FY2022 and a low of $12.8 million during FY2020.
  • Over the past 3 years, Candel Therapeutics' median Total Liabilities value was $25.1 million (recorded in 2021), while the average stood at $22.6 million.
  • Data for Candel Therapeutics' Total Liabilities shows a peak YoY skyrocketed of 96.09% (in 2021) over the last 5 years.
  • Candel Therapeutics' Total Liabilities (Yearly) stood at $12.8 million in 2020, then soared by 96.09% to $25.1 million in 2021, then rose by 19.58% to $30.0 million in 2022.